I saw two analyst valuations recently one I believe had Insulin at $2/share the other had it (along with the PEG-PH20 and cellulite) at zero. I agree with the later model. I'll be happy once insulin is off HALO's plate though I obviously hope they can get something for it, the more up-front the better as I don't see it being a blockbuster in any way.